Acute toxicity hypofractionated-IMRT vs standard radiotherapy in prostate cancer: comparative study

被引：0
|
作者：
Valero Albarran, J. [1 ]
Domingos da Silva, R. Guimaraes [2 ]
Payano, S. [1 ]
Montero, A. [1 ]
Sanchez, E. [1 ]
Chen, X. [1 ]
Hernando, O. [1 ]
Garcia Aranda, M. [1 ]
Ciervide, R. [1 ]
Lopez, M. [1 ]
Rubio, M. [1 ]
机构：
[1] Hosp Univ HM Sanchinarro, Radiat Oncol, Madrid, Spain
[2] Inst Natl Canc, Oncol Radiat, Rio De Janeiro, Brazil
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1384
引用
收藏
页码：S646 / S646
页数：1
相关论文
共 50 条
  • [21] ACUTE AND LATE TOXICITY OF PELVIC RADIOTHERAPY AND CONCOMITANT HYPOFRACTIONATED IMRT BOOST COMBINED WITH HORMONAL THERAPY FOR HIGH-RISK PROSTATE CANCER
    Quon, H.
    Loblaw, A.
    Morton, G.
    Sixel, K.
    Pang, G.
    Basran, P.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Thomas, G.
    Kiss, A.
    Deabreu, A.
    Cheung, P.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S47 - S47
  • [22] A dosimetric feasibility study of Conformal Radiotherapy (CRT) vs. hypofractionated CRT (HCRT) vs. Intensity Modulated Radiotherapy (IMRT) vs. Simultaneously Integrated Hypofractionated Boost IMRT (SIHB) in prostate adenocarcinoma
    Karvat, A
    Yu, C
    Kalach, N
    Liu, M
    Kristensen, S
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S338 - S338
  • [23] Acute Toxicity After CyberKnife-Delivered Hypofractionated Radiotherapy for Treatment of Prostate Cancer
    Townsend, Natasa C.
    Huth, Bradley J.
    Ding, William
    Garber, Bruce
    Mooreville, Michael
    Arrigo, Stephen
    Lamond, John
    Brady, Luther W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 6 - 10
  • [24] ACUTE TOXICITY IN PROSTATE CANCER PATIENTS TREATED WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY
    Bellavita, Rita
    Raymondi, Carlo
    Matrone, Fabio
    Massetti, Michela
    Lupattelli, Marco
    Arcidiacono, Fabio
    Mearini, Luigi
    Zucchetti, Claudio
    Palumbo, Isabella
    Aristei, Cynthia
    ANTICANCER RESEARCH, 2011, 31 (05) : 1912 - 1912
  • [25] ACUTE AND CHRONIC TOXICITY OF HYPOFRACTIONATED RADIOTHERAPY IN TREATMENT OF INTERMEDIATE-RISK PROSTATE CANCER
    Pagliuca, M. Di Genesio
    Di Staso, M.
    Bonfili, P.
    Gravina, G. L.
    Solda, F.
    Franzese, P.
    Tombolini, V.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S311 - S312
  • [26] Acute toxicity of hypofractionated IMRT with simultaneous integrated boost in high-risk prostate cancer patients
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    Souhami, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S689 - S689
  • [27] Radiotherapy of Prostate Cancer with IMRT and Proton Boost - Implementation of Image Guidance and Acute Toxicity
    Katayama, S.
    Heusel, A.
    Koerber, S.
    Debus, J.
    Herfarth, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S9 - S9
  • [28] Acute and Late Toxicity after Hypofractionated Intensity-modulated Radiotherapy for Localized Prostate Cancer
    Akimoto, T.
    Kiyozuka, M.
    Nasu, S.
    Motegi, A.
    Nakamura, K.
    Hashimoto, Y.
    Maebayashi, K.
    Hanyu, Y.
    Tanabe, K.
    Mitsuhashi, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S334 - S335
  • [29] Acute toxicity of moderately hypofractionated extended field radiotherapy in node-positive prostate cancer
    Periasamy, Kannan
    Sharma, Deepak
    Goyal, Shikha
    Singh, Ranjit
    Kumar, Santosh
    Mavuduru, Ravimohan
    Basher, Rajender
    Kumar, Narendra
    Madan, Renu
    Das, Chandan Krushna
    CLINICAL ONCOLOGY, 2022, 34 : E18 - E18
  • [30] Dose-escalated Hypofractionated IMRT in Localised Prostate Cancer: Toxicity and Outcome
    Thomson, D.
    Merrick, S.
    Swindell, R.
    Wylie, J.
    Cowan, R.
    Elliott, T.
    Logue, J.
    Livsey, J.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S56 - S56
12345